Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
Terzolo M, Baudin AE, Ardito A, Kroiss M, Leboulleux S, Daffara F, Perotti P, Feelders RA, deVries JH, Zaggia B, De Francia S, Volante M, Haak HR, Allolio B, Al Ghuzlan A, Fassnacht M, Berruti A. Terzolo M, et al. Among authors: ardito a. Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep. Eur J Endocrinol. 2013. PMID: 23704714 Free article.
Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S, Ardito A, Daffara F, Zaggia B, Germano A, Berruti A, Di Carlo F. De Francia S, et al. Among authors: ardito a. Minerva Endocrinol. 2012 Mar;37(1):9-23. Minerva Endocrinol. 2012. PMID: 22382612 Review.
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.
Berruti A, Sperone P, Ferrero A, Germano A, Ardito A, Priola AM, De Francia S, Volante M, Daffara F, Generali D, Leboulleux S, Perotti P, Baudin E, Papotti M, Terzolo M. Berruti A, et al. Among authors: ardito a. Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21. Eur J Endocrinol. 2012. PMID: 22189997 Clinical Trial.
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
D'Avolio A, De Francia S, Basile V, Cusato J, De Martino F, Pirro E, Piccione F, Ardito A, Zaggia B, Volante M, Di Perri G, Terzolo M. D'Avolio A, et al. Among authors: ardito a. Pharmacogenet Genomics. 2013 Jun;23(6):293-300. doi: 10.1097/FPC.0b013e3283606cb2. Pharmacogenet Genomics. 2013. PMID: 23524664 Free article.
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M. Berruti A, et al. Among authors: ardito a. Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14. Eur Urol. 2014. PMID: 24268504 Free article.
Management of adrenal cancer: a 2013 update.
Terzolo M, Daffara F, Ardito A, Zaggia B, Basile V, Ferrari L, Berruti A. Terzolo M, et al. Among authors: ardito a. J Endocrinol Invest. 2014 Mar;37(3):207-17. doi: 10.1007/s40618-013-0049-2. J Endocrinol Invest. 2014. PMID: 24458831 Free article. Review.
41 results